Cargando…
Polyamine Analog Diethylnorspermidine Restricts Coxsackievirus B3 and Is Overcome by 2A Protease Mutation In Vitro
Enteroviruses, including Coxsackievirus B3 (CVB3), are pervasive pathogens that cause significant disease, including cardiomyopathies. Unfortunately, no treatments or vaccines are available for infected individuals. We identified the host polyamine pathway as a potential drug target, as inhibiting p...
Autores principales: | Hulsebosch, Bridget M., Mounce, Bryan C. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7920041/ https://www.ncbi.nlm.nih.gov/pubmed/33669273 http://dx.doi.org/10.3390/v13020310 |
Ejemplares similares
-
Coxsackievirus B3 Responds to Polyamine Depletion via Enhancement of 2A and 3C Protease Activity
por: Dial, Courtney N., et al.
Publicado: (2019) -
Persistent Coxsackievirus B3 Infection in Pancreatic Ductal Cells In Vitro Downregulates Cellular Polyamine Metabolism
por: Mastrodomenico, Vincent, et al.
Publicado: (2023) -
Diverse Functions of Polyamines in Virus Infection
por: Firpo, Mason R., et al.
Publicado: (2020) -
Chikungunya Virus Overcomes Polyamine Depletion by Mutation of nsP1 and the Opal Stop Codon To Confer Enhanced Replication and Fitness
por: Mounce, Bryan C., et al.
Publicado: (2017) -
Benserazide, the first allosteric inhibitor of Coxsackievirus B3 3C protease()
por: Kim, Bo-Kyoung, et al.
Publicado: (2015)